We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$572B
AUM Growth
+$35.4B
Cap. Flow
+$12.6B
Cap. Flow %
2.21%
Top 10 Hldgs %
24.8%
Holding
13,475
New
1,572
Increased
5,247
Reduced
4,924
Closed
1,625

Sector Composition

Rank Sector Weight
1 Technology 1.85%
2 Consumer Discretionary 1.02%
3 Financials 0.76%
4 Communication Services 0.62%
5 Healthcare 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLAD icon
12301
Gladstone Capital
GLAD
$448M
-15,549
Closed -$362K
GLBS icon
12302
CALL
Globus Maritime Ltd
GLBS
$82.7M
-48,200
Closed -$90.1K
GLMD icon
12303
Galmed Pharmaceuticals
GLMD
$4.49M
-121
Closed -$3.33K
GSWO
12304
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.79B
-8,050
Closed -$377K
LKFT
12305
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
-30,842
Closed -$840K
GLRE icon
12306
CALL
Greenlight Captial
GLRE
$505M
-13,000
Closed -$170K
GLRE icon
12307
PUT
Greenlight Captial
GLRE
$505M
-16,000
Closed -$210K
DMRA
12308
Damora Therapeutics
DMRA
$1.89B
-6,734
Closed -$79.8K
GLTR icon
12309
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.88B
-21,325
Closed -$2.2M
GLUE icon
12310
PUT
Monte Rosa Therapeutics
GLUE
$1.24B
-12,100
Closed -$45.3K
CBIO
12311
CALL
Crescent Biopharma
CBIO
$631M
-11,702
Closed -$328K
GMED icon
12312
Globus Medical
GMED
$11.1B
-17,965
Closed -$1.27M
GMF icon
12313
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$429M
-16,272
Closed -$1.81M
GNMA icon
12314
iShares GNMA Bond ETF
GNMA
$436M
-13,434
Closed -$579K
GNOV icon
12315
FT Vest US Equity Moderate Buffer ETF November
GNOV
$300M
-31,037
Closed -$1.05M
GOCO
12316
DELISTED
GoHealth
GOCO
-14,751
Closed -$143K
GOOD
12317
Gladstone Commercial Corp
GOOD
$635M
-13,455
Closed -$202K
GOVI icon
12318
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.23B
-14,725
Closed -$406K
GPK icon
12319
CALL
Graphic Packaging
GPK
$3.38B
-48,600
Closed -$1.27M
GRBK icon
12320
Green Brick Partners
GRBK
$3.16B
-87,818
Closed -$6.34M
GRC icon
12321
CALL
Gorman-Rupp
GRC
$2.03B
-6,500
Closed -$239K
GRID
12322
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$11.7B
-29,372
Closed -$3.39M
GRND icon
12323
Grindr
GRND
$2.73B
-59,530
Closed -$705K
GRNQ icon
12324
Greenpro Capital
GRNQ
$21.9M
-1,680
Closed -$17.5K
GROW icon
12325
PUT
US Global Investors
GROW
$40.9M
-14,200
Closed -$37.1K

Similar funds

Jeff Yass's Q3 2024 Portfolio in Review

As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
  • Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
  • Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
  • Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
  • Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
  • Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.